Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Mattson Technology, Inc. (MTSN): Insiders Aren’t Crazy About It But Hedge Funds Love It

Page 1 of 2

At the moment, there are a multitude of indicators shareholders can use to monitor Mr. Market. A couple of the most underrated are hedge fund and insider trading interest. At Insider Monkey, our research analyses have shown that, historically, those who follow the top picks of the elite investment managers can outclass the S&P 500 by a healthy amount (see just how much).

Mattson Technology, Inc. (NASDAQ:MTSN)

Just as necessary, optimistic insider trading activity is a second way to analyze the investments you’re interested in. Just as you’d expect, there are many incentives for an upper level exec to sell shares of his or her company, but only one, very obvious reason why they would initiate a purchase. Many academic studies have demonstrated the market-beating potential of this method if investors understand what to do (learn more here).

Thus, we’re going to discuss the recent info surrounding Mattson Technology, Inc. (NASDAQ:MTSN).

What have hedge funds been doing with Mattson Technology, Inc. (NASDAQ:MTSN)?

At Q2’s end, a total of 9 of the hedge funds we track held long positions in this stock, a change of 80% from one quarter earlier. With hedgies’ sentiment swirling, there exists a few notable hedge fund managers who were increasing their holdings considerably.

According to our 13F database, Royce & Associates, managed by Chuck Royce, holds the largest position in Mattson Technology, Inc. (NASDAQ:MTSN). Royce & Associates has a $0.6 million position in the stock, comprising less than 0.1%% of its 13F portfolio. The second largest stake is held by PEAK6 Capital Management, managed by Matthew Hulsizer, which held a $0.4 million call position; less than 0.1%% of its 13F portfolio is allocated to the company. Some other peers that hold long positions include D. E. Shaw’s D E Shaw, Andy Redleaf’s Whitebox Advisors and Ben Levine, Andrew Manuel and Stefan Renold’s LMR Partners.

As one would understandably expect, certain money managers were breaking ground themselves. Royce & Associates, managed by Chuck Royce, created the most valuable position in Mattson Technology, Inc. (NASDAQ:MTSN). Royce & Associates had 0.6 million invested in the company at the end of the quarter. Matthew Hulsizer’s PEAK6 Capital Management also made a $0.4 million investment in the stock during the quarter. The following funds were also among the new MTSN investors: D. E. Shaw’s D E Shaw, Andy Redleaf’s Whitebox Advisors, and Ben Levine, Andrew Manuel and Stefan Renold’s LMR Partners.

What do corporate executives and insiders think about Mattson Technology, Inc. (NASDAQ:MTSN)?

Legal insider trading, particularly when it’s bullish, is most useful when the primary stock in question has seen transactions within the past 180 days. Over the last half-year time frame, Mattson Technology, Inc. (NASDAQ:MTSN) has seen zero unique insiders buying, and zero insider sales (see the details of insider trades here).

We’ll check out the relationship between both of these indicators in other stocks similar to Mattson Technology, Inc. (NASDAQ:MTSN). These stocks are Mindspeed Technologies, Inc. (NASDAQ:MSPD), Axcelis Technologies Inc (NASDAQ:ACLS), Oclaro, Inc. (NASDAQ:OCLR), Cascade Microtech, Inc. (NASDAQ:CSCD), and eMagin Corporation (NYSEAMEX:EMAN). All of these stocks are in the semiconductor equipment & materials industry and their market caps are similar to MTSN’s market cap.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!